Nan Yao
Nanjing University of Chinese Medicine(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Mechanisms and Therapy, Drug Transport and Resistance Mechanisms, Epigenetics and DNA Methylation
Most-Cited Works
- → Autophagy and multidrug resistance in cancer(2017)685 cited
- → Inhibition of PINK1/Parkin-dependent mitophagy sensitizes multidrug-resistant cancer cells to B5G1, a new betulinic acid analog(2019)147 cited
- → Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo(2015)101 cited
- → Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin(2017)65 cited
- → Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness(2020)63 cited
- → Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth(2020)45 cited
- → Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells(2015)44 cited
- → ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy(2023)38 cited
- → CD8+ T�cells stimulated by exosomes derived from RenCa cells mediate specific immune responses through the FasL/Fas signaling pathway and, combined with GM‑CSF and IL‑12, enhance the anti‑renal cortical adenocarcinoma effect(2019)37 cited
- → A piperazidine derivative of 23-hydroxy betulinic acid induces a mitochondria-derived ROS burst to trigger apoptotic cell death in hepatocellular carcinoma cells(2016)36 cited